Last reviewed · How we verify
PUR0200
At a glance
| Generic name | PUR0200 |
|---|---|
| Sponsor | Pulmatrix Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects (PHASE1)
- A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PUR0200 CI brief — competitive landscape report
- PUR0200 updates RSS · CI watch RSS
- Pulmatrix Inc. portfolio CI